Atriva Therapeutics GmbH

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Atriva Therapeutics GmbH - overview

Established

2015

Location

Tubingen, -, Germany

Primary Industry

Pharmaceuticals

About

Founded in 2015 and based in Tübingen, Germany, Atriva Therapeutics GmbH is a pharmaceutical company that develops novel therapeutics for the treatment of pandemic influenza.


Current Investors

High-Tech Gruenderfonds, Stichting Participatie Atriva , Meneldor

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Epidemiology, Healthcare Specialists, Pharmaceutical Research & Development

Website

www.atriva-therapeutics.com

Company Stage

Series A

Total Amount Raised

Subscriber access only

Atriva Therapeutics GmbH - financials

Fiscal Year EndedDec 31, 2020Dec 31, 2021Dec 31, 2022
Revenue (USD)---
% Revenue Growth (YoY)---
EBITDA (USD)---
Operating Income (USD)---
Operating Margin---
% EBITDA Margin---
NET Income (USD)---
% Net Margin---

Atriva Therapeutics GmbH - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Venture DebtCompletedAtriva Therapeutics GmbH-
Venture DebtCompletedAtriva Therapeutics GmbH-
Series ACompletedAtriva Therapeutics GmbH-
SeedCompletedAtriva Therapeutics GmbH-
SeedCompletedAtriva Therapeutics GmbH-

Displaying 1 - 5 of 5

Atriva Therapeutics GmbH - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.